The molecular interactions between hosts, vectors and pathogens drive the etiology of infectious diseases. At first sight, the Guillain-Barré and Alpha-Gal syndromes have quite different etiologies but, as proposed here, a closer look into the immune response to galactose-containing oligosaccharide structures that characterizes these two diseases reveals striking commonalities. In this Opinion paper, we address the main molecular drivers of two apparently unrelated diseases, and how the characterization of the immune response and immunological tolerance would advance the control and prevention of these diseases.
PDF) Expression of Early Growth Response Gene-2 and Regulated Cytokines Correlates with Recovery from Guillain–Barré Syndrome
PDF) Novel Case Presentation of Abulia After Lone Star Tick Bite As Evidenced by Raised Titers of Alpha-Gal Specific IgM Immunoglobulin and a Possibility of Alpha-Gal Driven Hypothalamic Dysfunction As the Pathomechanism
Adverse reactions to vaccine
Piccolo as a potential serological correlate of recovery from GBS. Sera
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
PDF) Guillain-Barré and Alpha-gal Syndromes: Saccharides-induced Immune Responses
Margarita VILLAR, Ph.D, University of Castilla-La Mancha, Ciudad Real, Biochemistry section of Inorganic Chemistry, Organic and Biochemistry Department and Instituto de Investigación en Recursos Cinegéticos (IREC)
PDF) Guillain-Barré and Alpha-gal Syndromes: Saccharides-induced Immune Responses
